Considering adjuvant therapy for stage II melanoma

por Poklepovic, Andrew S., Luke, Jason J.
Publicado 2019

Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies

por Dent, Paul, Booth, Laurence, Poklepovic, Andrew
Publicado 2019

Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species

por Roberts, Jane L., Poklepovic, Andrew, Booth, Laurence
Publicado 2017

Immunotherapy for Metastatic Melanoma with Right Atrial Involvement in a Patient with Rheumatoid Arthritis

por Benson, Zachary, Gordon, Sarah, Nicolato, Patricia, Poklepovic, Andrew
Publicado 2017

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2017

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2019

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells

por Roberts, Jane L., Booth, Laurence, Poklepovic, Andrew, Dent, Paul
Publicado 2021

Kinase inhibitors: look beyond the label on the bottle

por Dent, Paul, Poklepovic, Andrew, Booth, Laurence, Hancock, John F.
Publicado 2019

Rationally Repurposing Ruxolitinib (Jakafi(®)) as a Solid Tumor Therapeutic

por Tavallai, Mehrad, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2016

PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Gordon, Sarah, Dent, Paul
Publicado 2016

HDAC inhibitors enhance the immunotherapy response of melanoma cells

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Kirkwood, John, Dent, Paul
Publicado 2017

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Publicado 2020

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Publicado 2020

Multiple Immunotherapy-Related Cardiovascular Sequelae

por Menachery, Sherin M., Chuquin, David, Sindel, Ariel, Poklepovic, Andrew, Abbate, Antonio, Bottinor, Wendy
Publicado 2022

Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Cridebring, Derek, Reiman, Eric M.
Publicado 2021

Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS

por Tavallai, Mehrad, Booth, Laurence, Roberts, Jane L., McGuire, William P., Poklepovic, Andrew, Dent, Paul
Publicado 2016

Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo

por Booth, Laurence, Albers, Thomas, Roberts, Jane L., Tavallai, Mehrad, Poklepovic, Andrew, Lebedyeva, Iryna O., Dent, Paul
Publicado 2016

The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo

por Booth, Laurence, Roberts, Jane L., Sander, Cindy, Lee, John, Kirkwood, John M., Poklepovic, Andrew, Dent, Paul
Publicado 2017

AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Martinez, Jennifer, Cridebring, Derek, Reiman, Eric M.
Publicado 2022

Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma

por Lee, Hannah M., Alder, Laura, Nguyen, Matthew, Dougherty, Sean C., Qu, Yuesheng, Thacker, Leroy R., Poklepovic, Andrew
Publicado 2023